Metabolon Expands Inflammation Portfolio with Targeted Panels for Cannabinoids, Sphingolipids, and Lipid Mediators of Inflammation
- Written by PR Newswire
![]() |
Targeted metabolomics panels provide absolute quantitation to further scientific discovery and inflammation research
MORRISVILLE, N.C., Jan. 17, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, diagnostic, therapeutic development, and precision medicine applications,...